NINGBO INNO PHARMCHEM CO.,LTD. understands the critical importance of sourcing high-quality raw materials for the pharmaceutical industry. Methyl D-(-)-4-hydroxy-phenylglycinate (CAS 37763-23-8) is one such compound, serving as a vital pharmaceutical intermediate for synthesis. This guide aims to provide prospective buyers with essential information regarding its specifications and sourcing.

The primary characteristic that makes Methyl D-(-)-4-hydroxy-phenylglycinate so sought after is its role as a pharmaceutical intermediate for synthesis. It is a key building block in the production of various therapeutic agents, most notably antibiotics such as penicillin and cephalosporins. The effectiveness and safety of these final drug products are directly linked to the quality of the intermediates used in their synthesis. Therefore, understanding the specifications is crucial.

When considering purchasing Methyl D-(-)-4-hydroxy-phenylglycinate, buyers should pay close attention to its appearance, typically described as a white to off-white powder, and its assay, which is commonly specified at 98% or higher. These indicators reflect the purity and suitability of the compound for pharmaceutical applications. Reliable Methyl D-(-)-4-hydroxy-phenylglycinate suppliers, like NINGBO INNO PHARMCHEM CO.,LTD., ensure these specifications are consistently met.

The price of Methyl D-(-)-4-hydroxy-phenylglycinate can vary based on quantity, purity, and supplier. We advise potential customers to inquire about the price when making a purchase, especially for bulk orders, to ensure cost-effectiveness. For those engaged in chiral drugs synthesis, the consistent availability and quality of this intermediate are non-negotiable.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being a trusted partner for pharmaceutical manufacturers. We facilitate the procurement of Methyl D-(-)-4-hydroxy-phenylglycinate by offering transparent information about its properties and applications. Our commitment extends to ensuring that every batch meets the required pharmaceutical intermediate quality standard, thereby supporting your production goals and the development of safe and effective medicines.